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Tackling stigma: fundamental to an AIDS-free future
The achievement of an AIDS-free future will surely be a 
priority discussion topic at the upcoming International 
AIDS Society conference in Melbourne, Australia. The 
discovery that antiretroviral therapy (ART) limits HIV 
transmission1 follows several years of steady progress in 
controlling the epidemic, with the number of new HIV 
infections falling from 3·7 million in 1997 to 2·3 million, 
and AIDS deaths from 2·3 million in 2005 to 1·6 million 
in 2012.2 Nevertheless, the number of people living 
with HIV is still rising as the number of new infections 
exceeds the number of deaths in this group. Moreover, 
coverage of ART in people meeting even the 2010 WHO 
standard for treatment (ie, CD4 cell count <350 cells/μL) 
is still far from complete, and plans to expand treatment 
to cover all people living with HIV for the rest of their 
lives are viewed with scepticism by some people.3 Crucial 
international funding for HIV and AIDS has remained 
static for several years.2 Although funding from national 
budgets is rising, countries will ﬁ nd it very diﬃ  cult to 
cover the growing cost of treatment, especially when 
the more expansive 2013 WHO standard (ie, CD4 cell 
count <500 cells/μL) is applied. 
Sub-Saharan Africa remains the region most aﬀ ected 
by HIV, but the rapid scale-up of ART programmes 
has had clear results: the number of AIDS deaths—
which has risen steadily since the 1970s and peaked 
in 2004–05 at 1·8 million—fell to 1·2 million by 
2012.4 In the African region, an equally important 
but underappreciated reason for the recent decline 
in deaths is the peaking of new infections in 1997 
at 2·7 million. Most of the subsequent decrease to 
1·6 million new infections in 2012 occurred before ART 
became widely available in the mid-2000s. Instead, 
behavioural change in response to the threat of AIDS 
and to prevention eﬀ orts underlies this trend. Its eﬀ ect 
is well documented in Uganda and Zimbabwe,5,6 but 
reductions in risky behaviour have also occurred in 
other countries.2 One of the most striking trends since 
the early 1990s7 is the rise in condom use in women 
not in marital unions (ﬁ gure). This trend seems to be an 
important reason why infection rates in young women 
have fallen sharply. Without the change in behaviour 
and resulting decline in HIV incidence, the number of 
AIDS-related deaths in sub-Saharan Africa would now 
be substantially higher than it actually is.
However, millions of people are still becoming 
infected with HIV every year, and key populations such 
as sex workers, injection drug users, and men who have 
sex with men are disproportionately aﬀ ected. Compared 
with the general population, men who have sex with 
men and sex workers are 13·5 times more likely to be 
infected with HIV, and injection drug users are 20 times 
more likely to be infected with the virus.8 Although the 
overall prevalence of HIV is falling, epidemics in these 
key groups are expanding in many places worldwide.9 
Prevention of HIV in these marginalised groups is 
diﬃ  cult to address because of stigma, discrimination, 
and their sequelae.2,10,11 Key populations actually 
experience a double stigma related to both being 
associated with HIV and the reinforcement of pre-
existing stigmas.12 This situation has led to inadequate 
access to service provision and treatment, in addition 
to many other negative outcomes. Increasing evidence 
indicates that “prevention basics for key populations 
can be highly eﬀ ective”.13 Calls are growing to bring 
behavioural approaches, including harm reduction 
and condom promotion, “back to the centre of the 
debate for HIV prevention”.14,15 To more eﬀ ectively reach 
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key populations with the prevention basics, explicit 
reduction in HIV stigma should be made a priority. One 
notable example is HIV counselling and testing, a health 
system entry point that can address both prevention or 
treatment and care objectives, including treatment as 
prevention. Stigma inhibits the use of HIV counselling 
and testing, and evidence suggests that addressing of 
stigma will probably increase access to and use of HIV 
counselling and testing.16 
Stigma and discrimination experienced by sex workers, 
injection drug users, and men who have sex with men 
is tough to tackle. Responses need to be tailored to 
very diﬀ erent circumstances and require interventions 
on several levels: policy, societal, health system, and 
individual. There is no magic bullet response, however, 
many examples exist of stigma-reduction strategies and 
programmes with proven eﬀ ectiveness.17–19 The eﬀ ects 
of such programmes have often been limited because 
they are rarely taken to scale, and appropriate targeting 
to and tailoring for key populations has not been done 
frequently. 
Funding to address stigma confronts two problems: 
not only do general primary prevention strategies (such 
as the promotion of behaviour change) suﬀ er from 
“striking underfunding”3 but also prevention eﬀ orts 
for key populations remain minimum to non-existent 
throughout much of the world.2 Additionally, 90% of 
current HIV programme funds for sex workers, injection 
drug users, and men who have sex with men come 
from international donors.8 Without more political and 
economic commitment from local governments, the 
needs of key populations will be diﬃ  cult to address. 
It is hard to envision that signiﬁ cant progress will 
continue to be made in HIV prevention eﬀ orts with key 
populations without a prioritisation of stigma reduction 
and the allocation of adequate funding for behavioural 
and social change. The importance of tackling stigma 
has long been recognised, and now is the time to put 
stigma reduction at the forefront of programmatic 
responses. 
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